Psychedelic Startups, Biotech, Drug Discovery, Psilocybin, DMT, Psychedelics & Society | Sam Banister | #79
Mind & Matter · Nick Jikomes, PhD
Audio is streamed directly from the publisher (api.substack.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Nick talks to medicinal chemist Sam Banister, who is co-founder and Chief Science Officer at Psylo, a biotech startup focused on developing next-generation psychedelic medicines. They discuss: the past, present, and future of psychedelic science; Sam's journey from academia to biotech startup co-founder; Alexander Shulgin; psychedelics like psilocybin, DMT, and others; and psychedelics & society.
* Click here to download audio, watch video, or read show notes & transcripts.
* If you enjoy my content and want to further support M&M, please read this
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit mindandmatter.substack.com/subscribe